Why NAD+ Supplements Are a Waste of Money

Your body is not running low on NAD+ because it stopped making enough. It is running low because something is consuming it faster than it can be replaced, and that distinction changes everything about how you would fix it.

NAD+ is something called a coenzyme, which is a molecule your cells use to carry out hundreds of reactions, including the ones that produce energy, repair DNA, and regulate how genes get expressed. As you age, your levels drop significantly, and the supplement industry has built an entire category around the assumption that you need to put more in. But the research points somewhere else entirely.

To understand where the problem actually is, you need to see the whole chain first.

As your cells accumulate damage over time, some of them reach a point where they should self-destruct but do not. Instead they enter a state called senescence, which means they are still alive but no longer functioning properly. These cells are not quiet. They secrete a steady stream of inflammatory signals, and those signals trigger your immune system to respond. That immune response then activates an enzyme called CD38, which your immune cells use to produce the signaling molecules they need to keep fighting the damage. The fuel CD38 runs on is NAD+.

The more senescent cells you accumulate, the more your immune system stays activated, and the more NAD+ gets consumed in the process.

A 2016 study published in Cell Metabolism measured this directly. CD38 activity increases two to three fold across all tissues as you age, and the correlation between CD38 activity and NAD+ levels is nearly perfect in the inverse direction. When researchers eliminated CD38 in mice entirely, NAD+ levels stayed constant at every age. The mice aged without losing NAD+. That result tells you the problem is not synthesis. It is consumption.

The 2020 follow-up in Nature Metabolism traced the causal chain one step further back. Senescent cells secrete inflammatory cytokines that cause macrophages, which are the immune cells doing the consuming, to upregulate CD38 expression by up to 600-fold. That is not a small shift. The senescent cells are not directly burning the NAD+. They are triggering the immune response that does.

There is a second drain running in parallel.

When mitochondria are damaged, they activate repair enzymes called PARPs, which stands for poly ADP-ribose polymerases. PARPs use NAD+ as their raw material to build the molecular tags they attach to damaged DNA as part of the repair process. If your mitochondria are chronically stressed, your PARPs are chronically active, and your NAD+ is getting routed toward repair signaling instead of energy production.

So you have two drains open at the same time. One is immune-mediated through CD38, driven by senescent cells. The other is repair-mediated through PARPs, driven by damaged mitochondria. Taking an NAD+ precursor like NMN or NR while both of those drains are open is exactly like adding water to a bathtub without closing the drain and wondering why it never fills.

There is also a separate problem with the precursors themselves. A 2023 study in FEBS Letters found that gut bacteria deamidate NMN before it gets absorbed, converting it into nicotinic acid, which is just niacin. A Science Advances study confirmed the same pattern, finding that most oral NAD+ precursors become niacin-pathway metabolites in the gut before absorption. When researchers eliminated the gut microbiome with antibiotics, direct NMN uptake increased significantly, which confirms that the conversion is happening in the gut and not afterward. This means the expensive supplement you are taking is largely becoming the same compound you could buy for pennies.

A 2023 review in Science Advances looked at 25 human trials on nicotinamide riboside and concluded there is an unfortunate tendency in the literature to exaggerate the importance and robustness of reported effects. That is a direct quote from the researchers. The effect sizes in humans are not matching what was seen in mice, and the mechanistic reasons above help explain why.

So if the problem is consumption, the fix has to address what is doing the consuming.

Exercise is the first and most accessible intervention. A 2023 meta-analysis found that consistent exercise training increases expression of something called NAMPT, which is the enzyme responsible for recycling NAD+ back into usable form, by over 127 percent, with a large effect size measured at Cohen's d of 0.81. That is a meaningful biological shift available to anyone who trains consistently.

For the mitochondrial drain, a compound called SS-31 works by binding directly to cardiolipin, which is a lipid in the inner mitochondrial membrane that holds the electron transport chain in its functional geometry. When that geometry is disrupted by age or damage, electron flow becomes inefficient and reactive oxygen species increase, which keeps PARP activity elevated. SS-31 restores membrane geometry and reduces that downstream signaling. A 2020 study in Aging Cell found that neither SS-31 nor NMN alone significantly raised resting NAD levels in aged mouse hearts, but the combination did, and it best recapitulated the metabolic profile seen in young hearts. Closing the drain made the precursor effective.

For the senescent cell drain, a peptide called FOXO4-DRI selectively causes senescent cells to undergo apoptosis, which is the programmed cell death they were avoiding. Fewer senescent cells means less inflammatory signaling, which means less macrophage activation, which means less CD38 activity. You are addressing the source rather than managing the downstream effect.

The sequence matters. Fix the mitochondria, clear the senescent cells, and then if you want to provide precursor support, niacin costs almost nothing and gets to the same destination the expensive supplements are being converted into anyway.

Most people have been taught that NAD+ decline is a supply problem and that topping up the tank is the solution. The biology says the tank is draining. That is not a distinction the supplement industry benefits from explaining.

---

References

1. Camacho-Pereira J, Tarrago MG, Chini CCS, et al. CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism. Cell Metabolism. 2016;236:1127-1139. Finding: CD38 activity increases 2-3 fold with age across all tissues, with near-perfect inverse correlation to NAD+ levels. CD38 knockout mice maintained NAD+ at all ages. Source
2. Covarrubias AJ, Kale A, Perrone R, et al. Senescent cells promote tissue NAD+ decline during ageing via the activation of CD38+ macrophages. Nature Metabolism. 2020;211:1265-1283. Finding: Senescent cells secrete inflammatory cytokines that cause macrophages to upregulate CD38 expression up to 600-fold, establishing the causal chain from cellular senescence to NAD+ decline. Source
3. Kim LJ, Chalmers TJ, Madawala R, et al. Host-microbiome interactions in nicotinamide mononucleotide NMN deamidation. FEBS Letters. 2023;59717:2196-2207. Finding: Gut bacteria deamidate NMN before absorption, converting it to nicotinic acid niacin. Ablation of microbiome with antibiotics increased direct NMN uptake, confirming gut conversion. Source
4. Science Advances enterohepatic circulation study. Finding: NMN and NR facilitate NAD+ synthesis primarily through conversion to niacin-pathway metabolites in the gut, confirming that most oral precursors become niacin before absorption. Source
5. Sun X, Su L, Bu T, Zhang Y. Exercise training upregulates intracellular nicotinamide phosphoribosyltransferase expression in humans: a systematic review with meta-analysis. Frontiers in Public Health. 2023;11:1287421. Finding: Exercise training increases NAMPT expression by over 127% with a large effect size Cohen's d = 0.81. Source
6. Whitson JA, Martin SS, Zhang H, et al. SS-31 and NMN: Two paths to improve metabolism and function in aged hearts. Aging Cell. 2020;1910:e13213. Finding: Neither SS-31 nor NMN alone significantly increased resting NADH levels in aged mouse hearts. Only the combination did, best recapitulating the young state. Source
7. Brakedal B, Doring A, Riber C, et al. What is really known about the effects of nicotinamide riboside supplementation in humans. Science Advances. 2023;929:eadi4862. Finding: Review of 25 NR human studies concluded there is "an unfortunate tendency in the literature to exaggerate" the importance and robustness of reported effects. Source

---

Join the free community:
Men: Iron Forge Brotherhood
Women: Powerhouse Fitness